USA flag Sunday, August 1, 2021

Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act

$49,681,106

Total Assistance, FY 2008 to Present
Agency: CENTERS FOR MEDICARE AND MEDICAID SERVICES, HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Assistance Type: Not Applicable
Popular Name: Section 1003 Demonstration Project to Increase Substance Use Provider Capacity
CFDA Number
93.664

Objectives: Section 1003 of the SUPPORT Act amends Title XIX with a provision directing CMS, in consultation with the Substance Abuse and Mental Health Services Administration (SAMHSA), to conduct a 54-month demonstration project to increase the treatment capacity of providers participating in Medicaid to provide substance use disorder (SUD) treatment or recovery services. Planning grants were awarded to 15 states for the planning phase of the demonstration. Up to 5 states that receive planning grants will be selected to implement 36-month demonstrations. Planning Grants: For the planning phase of the project, under section 1003(aa)(2)(A) (I-IV)), the HHS Secretary awarded planning grants totaling $48.4 million to 15 states (based on geographic diversity, with a preference to states with a prevalence of opioid use disorders comparable to or higher than the national average). Planning grant activities include assessing the behavioral health treatment needs of the state and supporting the development of state infrastructure to recruit prospective providers to treat substance use disorders and training for those providers. The maximum time period for funding for planning grants is 18 months. Pursuant to section 1135(b)(5) of the Social Security Act (Act), the end date of the 18-month period for the planning phase of the SUPPORT Act section 1003 Substance Use Disorder Provider Capacity Demonstration is modified by 6 months to September 30, 2021. The start of the 36-month post-planning demonstration phase is modified by 6 months to October 1, 2021.

 
Top